Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Ryan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang, James A. Hoxie, Rosemarie Mick, Stephen G. Emerson, Yi Zhang, Robert H. Vonderheide, David L. Porter, Ran Reshef

Blood (2017) 129 (7): 906–916.

https://doi.org/10.1182/blood-2016-08-735076

Published: 2017

Includes: Supplemental data

Journal Articles

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Ran Reshef, MD, James K. Mangan, MDPhD, Selina M. Luger, MD, Alison Wakoff Loren, MDMS, Elizabeth O. Hexner, MD, Noelle V. Frey, MDMS, Edward A. Stadtmauer, MD, Robin E. Blauser, BSN RN, Lee P. Richman, BA, Austin P. Huffman, BA, Alex Ganetsky, PharmD, Edward P. Acosta, PharmD, James A. Hoxie, MD, Rosemarie Mick, MS, Robert H. Vonderheide, MDDPhil, David L. Porter, MD

Blood (2014) 124 (21): 2491.

https://doi.org/10.1182/blood.V124.21.2491.2491

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation without Hematopoietic Support for the Treatment of Hematological Malignancies in 125 Jehovah’s Witnesses

Shakira Jeanene Grant, MBBS, Patricia Ford, MD, Rosemarie Mick, MS, Gina Keck, RN

Blood (2014) 124 (21): 3976.

https://doi.org/10.1182/blood.V124.21.3976.3976

Published: 2014

Journal Articles

Outcomes of Patients with Refractory/Relapsed Diffuse Large B-Cell Lymphoma Who Progress After Autologous Stem Cell Transplantation in the Rituximab Era.

Sarah J. Nagle, MD, Kaitlin Woo, Rosemarie Mick, MS, Stephen J. Schuster, MD, Sunita D. Nasta, MD, Edward A. Stadtmauer, MD, Jakub Svoboda, MD

Blood (2012) 120 (21): 2689.

https://doi.org/10.1182/blood.V120.21.2689.2689

Published: 2012

Journal Articles

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

Blood (2012) 120 (21): 143.

https://doi.org/10.1182/blood.V120.21.143.143

Published: 2012

Journal Articles

Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein in AML Blasts During Trials Combining Sirolimus and Intensive Chemotherapy: Target Inhibition Enhances Response

Margaret Kasner, MD, Selina M. Luger, MD, Grace R Jeschke, Rosemarie Mick, MS, Martin Carroll, MD, Alexander E Perl, MD

Blood (2011) 118 (21): 230.

https://doi.org/10.1182/blood.V118.21.230.230

Published: 2011

Journal Articles

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

Ran Reshef, MD, Selina M. Luger, MD, Elizabeth O. Hexner, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Sunita D. Nasta, MD, Edward A. Stadtmauer, MD, Jacqueline Smith, CRNP, Rosemarie Mick, MS, Daniel F. Heitjan, PhD, James A. Hoxie, MD, Stephen G. Emerson, MD, PhD, Robert H. Vonderheide, MD, PhD, David L. Porter, MD

Blood (2011) 118 (21): 1011.

https://doi.org/10.1182/blood.V118.21.1011.1011

Published: 2011

Journal Articles

Whole Blood Donor Chimerism At Day 30 After Reduced Intensity Conditioned Allogeneic Stem-Cell Transplantation Predicts Disease Relapse, and Is Strongly Associated with Pretransplant Lymphodepletion

Ran Reshef, MD, Rosemarie Mick, MS, Pavel Vassilev, BS, Jacqueline Smith, CRNP, Elizabeth Hexner, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Edward A. Stadtmauer, MD, Selina M. Luger, MD, David L. Porter, MD

Blood (2011) 118 (21): 1939.

https://doi.org/10.1182/blood.V118.21.1939.1939

Published: 2011

Journal Articles

Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist

Ran Reshef, MD, Selina M. Luger, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Elizabeth O. Hexner, MD, Edward A. Stadtmauer, MD, Jacqueline Smith, CRNP, Rosemarie Mick, MS, Daniel F. Heitjan, PhD, Susan E. Shetzline, PhD, Gwenn-ael H. Danet-Desnoyers, PhD, Stephen G. Emerson, MD, PhD, James A. Hoxie, MD, Robert H. Vonderheide, MD, PhD, David L. Porter, MD

Blood (2010) 116 (21): 673.

https://doi.org/10.1182/blood.V116.21.673.673

Published: 2010

Journal Articles

Oligodeoxynucleotide-mediated inhibition of c- myb gene expression in autografted bone marrow: a pilot study

Selina M. Luger, Stephen G. O'Brien, Janina Ratajczak, Mariusz Z. Ratajczak, Rosemarie Mick, Edward A. Stadtmauer, Peter C. Nowell, John M. Goldman, Alan M. Gewirtz

Blood (2002) 99 (4): 1150–1158.

https://doi.org/10.1182/blood.V99.4.1150

Published: 2002

Journal Articles

Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

David L. Porter, Robert H. Collins, Jr, Christine Hardy, Nancy A. Kernan, William R. Drobyski, Sergio Giralt, Mary E.D. Flowers, James Casper, Ann Leahey, Pablo Parker, Rosemarie Mick, Bev Bate-Boyle, Roberta King, Joseph H. Antin

Blood (2000) 95 (4): 1214–1221.

https://doi.org/10.1182/blood.V95.4.1214.004k46_1214_1221

Published: 2000

Journal Articles

In Vitro and In Vivo Evidence That Ex Vivo Cytokine Priming of Donor Marrow Cells May Ameliorate Posttransplant Thrombocytopenia

Mariusz Z. Ratajczak, Janina Ratajczak, Boguslaw Machalinski, Rosemarie Mick, Alan M. Gewirtz

Blood (1998) 91 (1): 353–359.

https://doi.org/10.1182/blood.V91.1.353

Published: 1998

NARROW

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Autologous Stem Cell Transplantation without Hematopoietic Support for the Treatment of Hematological Malignancies in 125 Jehovah’s Witnesses

Outcomes of Patients with Refractory/Relapsed Diffuse Large B-Cell Lymphoma Who Progress After Autologous Stem Cell Transplantation in the Rituximab Era.

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein in AML Blasts During Trials Combining Sirolimus and Intensive Chemotherapy: Target Inhibition Enhances Response

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

Whole Blood Donor Chimerism At Day 30 After Reduced Intensity Conditioned Allogeneic Stem-Cell Transplantation Predicts Disease Relapse, and Is Strongly Associated with Pretransplant Lymphodepletion

Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist

Oligodeoxynucleotide-mediated inhibition of c- myb gene expression in autografted bone marrow: a pilot study

Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

In Vitro and In Vivo Evidence That Ex Vivo Cytokine Priming of Donor Marrow Cells May Ameliorate Posttransplant Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only